Table 5.
Comparison of serum magnesium values between the kanamycin-based group and the capreomycin-based group at the initial visit, first month, and second month of treatment.
| N | Magnesium | p value | |||
|---|---|---|---|---|---|
| Mean ± SD (mg/dL) | Min-max (mg/dL) | ||||
| Initial visit | Kanamycin | 34 | 2.33 ± 0.21 | 1.80–2.75 | 0.082 |
| Capreomycin | 19 | 2.23 ± 0.18 | 1.94–2.58 | ||
|
| |||||
| First month | Kanamycin | 34 | 2.11 ± 0.20 | 1.63–2.55 | 0.883 |
| Capreomycin | 19 | 2.13 ± 0.34 | 1.30–2.55 | ||
|
| |||||
| Second month | Kanamycin | 34 | 2.11 ± 0.23 | 1.51–2.60 | 0.183 |
| Capreomycin | 19 | 1.96 ± 0.51 | 0.80–2.73 | ||
SD, standard deviation; min, minimum value; max, maximum value; analyzed using the unpaired t-test.